1. Home
  2. IBP vs CYTK Comparison

IBP vs CYTK Comparison

Compare IBP & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Installed Building Products Inc.

IBP

Installed Building Products Inc.

HOLD

Current Price

$260.68

Market Cap

7.2B

ML Signal

HOLD

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$65.24

Market Cap

7.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IBP
CYTK
Founded
1977
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.2B
7.6B
IPO Year
2014
2004

Fundamental Metrics

Financial Performance
Metric
IBP
CYTK
Price
$260.68
$65.24
Analyst Decision
Hold
Strong Buy
Analyst Count
8
18
Target Price
$278.57
$88.94
AVG Volume (30 Days)
289.8K
1.9M
Earning Date
05-07-2026
05-05-2026
Dividend Yield
1.26%
N/A
EPS Growth
6.70
N/A
EPS
9.71
N/A
Revenue
$2,970,800,000.00
$13,368,000.00
Revenue This Year
$2.09
$6.88
Revenue Next Year
$4.32
$308.26
P/E Ratio
$27.58
N/A
Revenue Growth
1.00
N/A
52 Week Low
$150.83
$29.31
52 Week High
$349.00
$70.98

Technical Indicators

Market Signals
Indicator
IBP
CYTK
Relative Strength Index (RSI) 39.15 56.34
Support Level $254.38 $59.12
Resistance Level $277.05 $69.67
Average True Range (ATR) 11.26 2.41
MACD 0.73 0.52
Stochastic Oscillator 28.43 66.74

Price Performance

Historical Comparison
IBP
CYTK

About IBP Installed Building Products Inc.

Installed Building Products Inc is an insulation installer serving the residential new construction market and are also a diversified installer of complementary building products, including waterproofing, fire-stopping and fireproofing, garage doors, rain gutters, window blinds, shower doors, closet shelving, mirrors and other products throughout the United States. The company installs fiberglass insulation, spray foam insulation, and cellulose insulation. The company has three operating segments consisting of Installation, Manufacturing and Distribution operations. Majority of revenue is derived from Installation segment.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: